Dating Startups Pioneer Verification Tools to Combat Fake Profiles Roundhill Memory ETF Surges 85 Since Debut Becoming FastestGrowing Fund on Record Nebius Group to Present at BofA Global Technology Conference Potential Catalyst for AIFocused Firm Kevin Warshs Potential Fed Policy Shift A Slimmer Role in Wall Streets Plumbing Trump Reverses AI Executive Order Dropping Safety Review Requirement for New Models Saudi Arabia Faces Mounting Competition for Asian Oil Market Share NextEra Energy NEE Q1 2026 Earnings EPS Beats Estimates by 125 as Renewable and Regulated Segments Drive Performance Perdoceo Education Corporation PRDO Q1 2026 Earnings EPS Surpasses Estimates with 5 Surprise ABX Q1 2026 Earnings Marginal EPS Miss Amid Positive Stock Reaction GSIT Q1 2026 Earnings Narrower Loss Drives Stock Rally IDR Q1 2026 Earnings EPS Miss Weighs on Shares as Strategic Priorities Continue PHI Q1 2026 Earnings EPS Falls Slightly Short of Estimates Stock Edges Higher Guardian Metal Resources PLC GMTL Surges 75 Bullish Momentum Builds Above Key Support Exponent Inc EXPO Climbs Nearly 3 as Stock Approaches Key Resistance Ategrity Specialty Insurance ASIC Edges Higher Approaching Resistance Constellium CSTM Rallies 3 Approaching Key Resistance at 3673 Paramount Gold Nevada Corp PZG Slips 148 as Technical Indicators Suggest Potential Consolidation Lloyds Potential Halifax Brand Retirement Stirs Local and Financial Concerns CIMN Q1 2026 Earnings EPS Beats Estimates Amid Steady Performance CRA International CRAI Holds Near 145 as Modest Pullback Tests Support Zone Yorkville Acquisition Corp Unit MCGAU Holds Steady at 1029 A Static SPAC Unit Under Scrutiny Navios Maritime Partners NMM Holds Steady Near Support as Shipping Sector Faces Mixed Signals Lithia Motors LAD Edges Higher Amid Steady Trading Key Levels in Focus Emergent BioSolutions EBS Slips 142 as Stock Navigates Key Support Levels Franklin Universal Trust FT Edges Higher Approaching Key Resistance Zone Waldencast Warrants WALDW Edge Higher at 004 Amid Tight Trading Range Acumen Pharmaceuticals ABOS Gains Nearly 5 as Stock Tests Resistance at 267